Medicina Health Care enjoys different business relations with multinational partners forming strategic marketing alliance, among which lies our strategic alliance with :
ORM DEVELOPMENT INC.
Web : www.hmcast.co.kr
AngioLab, founded in 1999, is a biotechnology company developing angiogenesis inhibitors and stimulators. AngioLab,concentrates on screening anti-angiogenic materials from various sources and has valuable candidates including herbal extracts, synthetic organic compounds, and peptide/ proteins. AngioLab has pharmaceutical and nutraceutical compositions with several anti-angiogenic candidates